MOPH

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
L04AX02	THALIDOMIDE CELGENE	B	Thalidomide - 50mg	50mg	Capsule	27,387,764 L.L
L04AX02	THALIDOMIDE BMS	B	Thalidomide - 50mg	50mg	Capsule	27,387,764 L.L
R05FA02	TUSCALMAN A	B	Noscapine HCl - 5mg, Guaifenesin - 25mg		Suppository	345,368 L.L
R05FA02	TUSCALMAN B	B	Noscapine HCl - 10mg, Guaifenesin - 50mg		Suppository	345,368 L.L
B02BC30-V03AK	TISSEEL LYO	B	Fibrinogen, human (clottable protein) (I) - 91mg/ml, Aprotinin, synthetic (I) - 3000KIU/ml, Thrombin, Human (II) - 500IU/ml, Calcium chloride (II) - 40?mol/ml		Injectable powder for solution + solution	53,437,592 L.L
B02BC30-V03AK	TISSEEL LYO	B	Fibrinogen, human (clottable protein) (I) - 91mg/ml, Aprotinin, synthetic (I) - 3000KIU/ml, Thrombin, Human (II) - 500IU/ml, Calcium chloride (II) - 40?mol/ml		Injectable powder for solution + solution	24,369,850 L.L
A10BH05	TRAJENTA	B	Linagliptin - 5mg	5mg	Tablet, film coated	3,213,127 L.L
B02BC30-V03AK	TISSEEL LYO	B	Fibrinogen, human (clottable protein) (I) - 91mg/ml, Aprotinin, synthetic (I) - 3000KIU/ml, Thrombin, Human (II) - 500IU/ml, Calcium chloride (II) - 40?mol/ml		Injectable powder for solution + solution	13,394,024 L.L
N05AX13	TREVICTA	B	Paliperidone - 175mg	175mg	Injectable suspension, prolonged release	34,656,697 L.L
N05AX13	TREVICTA	B	Paliperidone - 263mg	263mg	Injectable suspension, prolonged release	41,111,773 L.L
N05AX13	TREVICTA	B	Paliperidone - 350mg	350mg	Injectable suspension, prolonged release	49,493,727 L.L
N05AX13	TREVICTA	B	Paliperidone - 525mg	525mg	Injectable suspension, prolonged release	72,119,224 L.L
D06AX	TRIPLE ANTIBIOTIC ORIGINAL OINTMENT		Bacitracin - 400U, Neomycin (sulfate) - 3.5mg, Polymyxin B (sulfate) - 5000U			580,540 L.L
J01CR05	TAZOBACT		Piperacillin sodium - 4g, Tazobactam (sodium) - 500mg			783,460 L.L
S01EE04	TRAVOPROST BIOGARAN		Travoprost - 40mcg/ml	40mcg/ml	Drops solution	564,414 L.L